How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

Annals of the Rheumatic Diseases

Volumn 70, Issue 6, 2011, Pages 1010-1015

  Neovius, Martin ^a   Simard, Julia F ^a   Askling, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISABILITY; EARLY DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE COST; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PENSION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SOCIOECONOMICS; UNEMPLOYMENT;

ADULT; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; DISABLED PERSONS; EDUCATIONAL STATUS; EFFICIENCY, ORGANIZATIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PENSIONS; REGISTRIES; SICK LEAVE; SWEDEN; TIME FACTORS; UNEMPLOYMENT; YOUNG ADULT;

EID: 79955868039     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.136812     Document Type: Article

References (25)

1. Björk M, Thyberg I, Rikner K, et al. Sick leave before and after diagnosis of rheumatoid arthritis - a report from the Swedish TIRA project. J Rheumatol 2009 ; 36 : 1170-9.
2. Hallert E, Husberg M, Skogh T. Costs and course of disease and function in early rheumatoid arthritis: a 3-year follow-up (the Swedish TIRA project). Rheumatology (Oxford) 2006 ; 45 : 325-31. (Pubitemid 43372849) (Pubitemid 43372849)
3. Fex E, Larsson BM, Nived K, et al. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol 1998 ; 25 : 44-50. (Pubitemid 28060116) (Pubitemid 28060116)
4. Puolakka K, Kautiainen H, Pekurinen M, et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2006 ; 65 : 899-904.
5. Burton W, Morrison A, Maclean R, et al. Systematic review of studies of productivity loss due to rheumatoid arthritis. Occup Med (Lond) 2006 ; 56 : 18-27. (Pubitemid 43103362) (Pubitemid 43103362)
6. Kvien T K. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2 004; 22( 2 Suppl 1) :1-12. (Pubitemid 38269929) (Pubitemid 38269929)
7. Jacobsson L T, Lindroth Y, Marsal L, et al. Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden. Scand J Rheumatol 2007 ; 36 : 179-83. (Pubitemid 47174541) (Pubitemid 47174541)
8. Askling J, Fored CM, Geborek P, et al. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 2006 ; 65 : 707-12. (Pubitemid 43799167) (Pubitemid 43799167)
9. Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis Published Online First: 13 December 2010.
10. Eberhardt K, Larsson BM, Nived K, et al. Work disability in rheumatoid arthritis - development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007 ; 34 : 481-7. (Pubitemid 46364001) (Pubitemid 46364001)
11. Puolakka K, Kautiainen H, Möttönen T, et al. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial. Arthritis Rheum 2004 ; 50 : 55-62. (Pubitemid 38084287) (Pubitemid 38084287)
12. Neovius M, Sundstrom A, Simard J, et al. Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009. Scand J Rheumatol 2011; 40 :8-15.
13. Augustsson J, Neovius M, Cullinane-Carli C, et al. Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry). Ann Rheum Dis 2010 ; 69 : 126-31.
14. Wolfe F, Michaud K. The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study. Arthritis Res Ther 2010 ; 12 : R35.
15. Yelin E, Trupin L, Katz P, et al. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis. Arthritis Rheum 2003 ; 48 : 3046-54. (Pubitemid 37409314) (Pubitemid 37409314)
16. Mittendorf T, Dietz B, Sterz R, et al. Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective. Rheumatology (Oxford) 2008 ; 47 : 188-93. (Pubitemid 351168230) (Pubitemid 351168230)
17. Halpern MT, Cifaldi MA, Kvien TK. Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registrybased control group. Ann Rheum Dis 2009 ; 68 : 930-7.
18. Voss M, Stark S, Alfredsson L, et al. Comparisons of self-reported and register data on sickness absence among public employees in Sweden. Occup Environ Med 2008 ; 65 : 61-7.
19. Reisine S, Fifield J, Walsh S, et al. W ork disability among two cohorts of women with recent-onset rheumatoid arthritis: a survival analysis. Arthritis Rheum 2007 ; 57 : 372-80. (Pubitemid 46682523) (Pubitemid 46682523)
20. Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2000 ; 39 : 28-33. (Pubitemid 30095403) (Pubitemid 30095403)
21. Neovius M, Simard J, Sundström A, et al. Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register. Ann Rheum Dis 2011 ; 70 : 516-19.
22. Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953 ; 249 : 553-6.
23. Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol 1981 ; 10 : 301-6. (Pubitemid 12236226) (Pubitemid 12236226)
24. Neovius M, Sundström J, Rasmussen F. Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study. BMJ 2009 ; 338 : b496.
25. Neovius K, Neovius M, Rasmussen F. The combined effects of overweight and smoking in late adolescence on subsequent disability pension: a nationwide cohort study. Int J Obes (Lond) 2010 ; 34 : 75-82.